MailBuild Complex Newsletter Template

BioBusiness Network isn’t focused on being the biggest biopartnering event. (After all, how many people can you realistically meet over two days?) What WBR guarantees you is high-quality networking and face-to-face time with all the people you want to meet, deliberately capping the number of attendees to ensure the event remains intimate and effective for networking. No one wants to spend their days fighting through crowds of irrelevant people and BioBusiness Network cuts them out to help you ensure all your conversations have a focused business goal in mind.

Editor's corner

Welcome to our first newsletter of Q2. From here on in our newsletter will be taking on a slightly different style as we merge our Dealmakers Newlsetter and Dealmakers Round-Up together into one fortnightly update.

Despite the impact of the credit crisis and recession on the economy, partnering in the life sciences sector has continued to remain robust during quarter 1. Wildwood Ventures Director Dr. Tim Martin shares his own views on the highest value partnering deals from Q1, read his article here...

Let me know what you think? If you have any comments I'd love to hear from you! You can email me at claire@currentpartnering.com and I can incorporate valuable perspectives into our newsletters moving forward, giving you an opportunity to have your views read by thousands of industry professionals.....

Scorecard update

Our Scorecard Index provides a simple overview of recent partnering and M&A activity - see it now - Scorecard Index.

In additon, we track the leading deals by value in the current year, plus a compendium of top deals by value since 2000 - view details at Scorecard.

Latest update! Bigpharma partnering activity 2006 to present - view details here

In the news

The following are just some of the deals involving bigpharma announced in the last few weeks:

Keep posted on the latest deals and alliances with CurrentPartnering's In the news feature.

You can also view our daily news feed, comment on the latest stories in the media and benefit from spontaneous CurrentPartnering report offers by joining our group on Facebook

Partnering roundup

Articles of the month

Current Partnering seeks out the best articles from various sources, to keep you updated on partnering best practice, processes, latest trends and regulations:

On the 20th of June 1995 the first euroPLX Meeting was held in Frankfurt, Germany. At that time it was called “European Pharma Licensing Meeting”, a name which was later changed to European Pharma License Exchange, or euroPLX, for short. The beginnings were humble and difficult: Nobody had ever heard of a conference that did not feature speakers, lectures, or presentations... more

The weight loss and obesity management market hit a high today with the news that Arena Pharmaceuticals have gained a new a supply and marketing agreement for lorcaserin with Eisai in the US. More

Celgene has acquired Abraxis for $2.9 billion in a cash and stock transaction. This acquisition will enable Celgene to continue with their drive and commitment to broaden their market share from hematology treatments into solid tumor medicine. More

sanofi-aventis strengthens presence in oncology market with acquisition of TargeGen

Big price for small molecules? The price for increasing your market presence for the treatment of leukaemia, lymphoma and blood disorders through the acquisition of a privately held US biopharmaceutical company has been determined by sanofi-aventis to be $560 million. More

New and updated reports

Provides comprehensive understanding and unprecedented access to the pre-clinical stage partnering agreements entered into by the worlds leading biopharma companies Buy now

UPDATED: Option & Evaluation Agreements in Pharma and Biotech

Providing detailed understanding and analysis of how and why companies enter option and evaluation deals, plus access to actual option and evaluation agreements Buy now

NEW: Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd edition

provides detailed understanding and analysis of how and why companies enter royalty financing deals Buy now

NEW: Clinical Stage Partnering Terms and Agreements in Pharma and Biotech, 2nd edition

Provides comprehensive understanding and unprecedented access to the clinical stage partnering agreements entered into by the worlds leading biopharma companies. Buy now

UPDATED: Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 3rd edition

Providing detailed understanding and analysis of how and why companies enter co-promotion and co-marketing deals, plus access to actual agreements. Buy now

UPDATED: Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 3rd edition

Providing detailed understanding and analysis of how and why companies enter M&A deals, plus access to actual M&A agreements. Buy now

NEW: Partnering Agreements with Bigpharma

Partnering Agreements with Bigpharma report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty biopharma companies. Buy now

Forthcoming partnering events

People on the move

If you have news about a business development executive who is on the move - let us know

Partnering resources

Current Partnering maintains and regularly updates this list of useful resources for dealmakers across all industries.

Advertizing and sponsorship

CurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online.

About Currentpartnering

CurrentPartnering is an online provider of best practice, business information and intelligence for deal makers. We search out the latest information so you don’t have to and place it in one location, saving you precious time and resources.

Mail: Wildwood Ventures Ltd., Eco Business Centre, Amy Johnson Way, Clifton Moor, York, YO30 4AG, United Kingdom

Dealmakers Update - July 2010